Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue    
Total revenue $ 81
Operating expenses:    
Research and development, net of reimbursements 30,045 38,670
General and administrative 12,076 13,331
Total operating expenses 42,121 52,001
Loss from operations (42,121) (51,920)
Other income:    
Interest income – net 3,878 3,102
Total other income 3,878 3,102
Net loss $ (38,243) $ (48,818)
Net loss per common share – basic and diluted (in Dollars per share) $ (1.27) $ (1.83)
Net loss per common share – diluted (in Dollars per share) $ (1.27) $ (1.83)
Weighted average common shares outstanding – basic and diluted (in Shares) 30,070,028 26,604,045
Weighted average common shares outstanding – diluted (in Shares) 30,070,028 26,604,045
Revenue    
Revenue    
Total revenue
Other Revenue    
Revenue    
Total revenue $ 81